gemcitabine [clinicaltrials_resource:e048c8ab5130a2f464d763b47f6d9b50]
intervention [clinicaltrials_vocabulary:intervention]
gemcitabine [clinicaltrials_resource:e048c8ab5130a2f464d763b47f6d9b50]
Bio2RDF identifier
e048c8ab5130a2f464d763b47f6d9b50
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e048c8ab5130a2f464d763b47f6d9b50
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
1200 mg/m2 IV days 1 and 8 every 3 weeks for a maximum of 6 cycles
intervention name [clinicaltrials_vocabulary:intervention-name]
gemcitabine
identifier
clinicaltrials_resource:e048c8ab5130a2f464d763b47f6d9b50
title
gemcitabine
@en
type
label
gemcitabine [clinicaltrials_resource:e048c8ab5130a2f464d763b47f6d9b50]
@en